Recently published biotechnology category reports

January 29, 2013

We have some new market research reports in the biotechnology category which may be beneficial for you.

Take a look at our recently published biotechnology category reports. These are: –

Biologic Therapeutic Drugs: Technologies and Global Markets (BIO079B)

In the 1970s, developments under way that began during World War II ushered in the biotechnology revolution. A pattern of increasing interdependence between pharma and biotech evolved.  Both areas of the industry sought shared risk and lower costs for research.  The result of this collaborative industry has been the development of the biopharmaceutical industry, or biopharma.

The biopharmaceutical sector that emerged is one with extraordinary research demands and, at the same time, phenomenal research promise. This research study provides biologics market overview including information on competitive analysis, geographic distribution of biologics market, merger and acquisitions in biologics area and patents for biologic drugs.

Biologic Imaging Reagents: Technologies and Global Markets (BIO064B)

Biologic imaging reagents comprise an extremely diverse range of technologies and applications.  Imaging reagents are core, enabling technologies in molecular biology, biotechnology, pharmaceuticals and medicine.  Reagents help to detect key molecular and biological processes, and they function as biomarkers in the detection and diagnosis of diseases.

This research report covers the technologies and markets for the following biologic imaging reagents:  fluorescent dyes and probes, fluorescent proteins, nanoparticles (including quantum dots), supermolecules, imaging radiopharmaceuticals and contrast reagents for X-ray/CT, MRI and ultrasound.

Global Markets for Nanoparticle Size Analysis Instrumentation in the Life Sciences (BIO114A)

This report will provide an overview of the various types of instrumentation currently on the market for nanoparticle analysis and highlight new advances in this area.  At present, the U.S. holds the largest number of patents in the nanoparticle area.  This is largely due to the early commercialization of some nanoparticle products by U.S. companies.  It also reflects a larger contribution to the research and development of new ideas by American companies than by those in most other countries.

Global Markets and Technologies for Cell and Tissue Analysis (BIO068B)

The increasing field of cancer research and development is allowing for a focus on cell and tissue analysis products, which play important roles in such areas as the diagnosis of various forms of cancer and other diseases.  These products also assume pivotal roles when it comes to understanding diverse cellular activities.

The cell and tissue analysis (CTA) market is seeing an increasing number of novel analysis products being utilized in the current industry.  This industry is seeing an increase in the development of next-generation cell-analysis tools that target cancers and other diseases, including autoimmune diseases. This report reviews the global market for CTA and provides a detailed analysis.

Single-Use Technologies for Biopharmaceuticals: Global Markets (BIO099A)

Significant changes in biomanufacturing are expected due to the emergence of single-use systems in the commercial stage.  The advantages of single-use technologies such as faster changeovers, reduction in the risk of contamination, improvements over stainless steel systems in cleaning and validation, and a significant reduction in the time and costs involved in setting up a new facility have been key drivers in their adoption in research and development (R&D) and scale-up. This research study will provide an overview of single-use technologies market by technology, end users and applications. It will also highlight prevalent market strategies and competitive environment in the industry.

For a complete listing of report titles for biotechnology, please visit

Apart from the above reports, there are some upcoming reports which you might be interested in. List of such reports is given below: –

  • Top Ten Suppliers of Synthetic Biology Technology (BIO119A)
  • Immunoassays: Technologies and Global Markets (BIO033B)
  • Metabolomics: Technologies and Global Markets (BIO055A)
  • Molecular Diagnostics: Technologies and Global Markets (BIO063B)
  • Proteomics: Technologies and Global Markets (BIO034C)
  • Bioinformatics: Technologies and Global Markets (BIO051B)

For more information on upcoming reports on various categories please click here.


Global Market for DNA Sequencing Worth $1.7 Billion by 2013

August 11, 2008

Wellesley, Mass—According to a new technical market research report, DNA SEQUENCING: EMERGING TECHNOLOGIES AND APPLICATIONS (BIO045B) from BCC Research, the global market for DNA sequencing technology was worth $794.0 million in 2007 and an estimated $862.5 million in 2008. This should increase to $1.7 billion by 2013, a compound annual growth rate (CAGR) of 14.7%.

The market is broken down into the segments of research/drug discovery and development, commercial applications and emerging applications. Research/drug discovery and development has the largest share of the market, generating $600.4 million in 2007. This is expected to increase to $640.6 million in 2008 and over $1.0 billion in 2013, for a CAGR of 9.7%.

Commercial applications have the next largest share of the market, worth $193.6 million in 2007 and an estimated $218.8 million in 2008. This should increase at a CAGR of 14.3% to reach $426.1 million in 2013.

Emerging applications have the smallest but fastest growing share of the market. This sector is expected to generate $3.1 million by the end of 2008 and $272.5 million in 2013, for a CAGR of 144.8%.

DNA sequencing allows us to catalogue the variations within the human genome sequence that make us phenotypically different, and that cause resistance and susceptibility to disease. The rapidly evolving sequencing technologies provide unprecedented analytical tools that allow us to identify this sequence variation, in humans as well as in other species.

Technology and market forces are working a fundamental shift in the DNA sequencing industry away from stagnant/declining growth towards high growth. This growth inflection signals the arrival of DNA sequencing as a premier genetic analysis tool: useful for existing applications such as de novo whole genome sequencing and entirely new applications like epigenetic tag sequencing.

($ millions)

read more | digg story

Bookmark and Share

Stem Cell Development Continuing at a Blistering Speed

August 1, 2008


Wellesley, Mass—According to a new technical market research report, STEM CELL TECHNOLOGY: CURRENT APPLICATIONS AND FUTURE DIRECTIONS (BIO035C) from BCC Research, the domestic market for stem cell technology is expected to increase from $112.0 million in 2007 to $423.1 million in 2012, a compound annual growth rate (CAGR) of 30.5%

The market is divided into cellular therapeutics and therapeutic banking categories. Stem cells in therapeutic banking have the larger share of the market, worth $65.9 million in 2007 and expected to increase to $155.7 million in 2012, for a CAGR of 18.8%.

Cellular therapeutics should be the faster growing segment. Cellular therapeutics generated $46.1 million in 2007 and is expected to generate $267.4 million in 2012, a CAGR of 42.1%.

The advent of stem cell technology has reignited the regenerative medicine market with hopes of powerful new therapeutics geared towards addressing unmet healthcare needs such as cardiovascular disease, neurological diseases, metabolic diseases, organ failure, a wide range of injuries, and even age related degeneration.

Although stem cell based therapeutics hold great promise, the delivery of actual readily available treatments is still projected to be at least five if not 10 or more years away. People looking to capitalize on the potential future therapeutic applications of stem cells have been preserving their stem cells, and stem cell banking has become a slow but growing market.

Stem cell research and development will continue to play a significant role in the present and future commercialization of stem cell based products and services and may develop into a substantial parallel market to stem cell based therapeutics as these tools mature, and potentially move into adjacent life science markets such as pharmaceutical testing and drug discovery.

Contact: Jason W. Prokowiew

Tel: 978-870-3345


read more | digg story

Bookmark and Share

Minimally Invasive Means Big Market Potential

June 27, 2008

Efforts to improve micromachining and materials show that the minimally invasive device manufacturing trend is growing.

read more | digg story

Bookmark and Share

Biotechnology has a Promising Future

May 23, 2008

According to a new technical market research report, Environmental Markets for Biotechnology, the U.S. market for environmental biotechnology products for waste treatment is expected to be worth $ 180.2 million in 2008. This is expected to increase to $ 261.3 million by 2013, a compound average annual growth rate (CAGR) of 7.7%. The market is broken down into applications of microbial blends, nutrients, enzymes and microbes. Of these, ­microbial blends have the largest share of the environmental biotechnology market. Expected to be worth $ 89.2 million in 2008, this segment will increase to $ 130.6 million in 2013 for a CAGR of 7.9%.¹

¹BCC Research;

² Process-Worldwide, Chemical and Pharmaceutical Engineering

read more | digg story

Bookmark and Share

Value ‘add’itives

April 21, 2008

Additives are key ingredients of most medicines. This may be the reason why additives have been inseparable from pharma industry despite having a few drawbacks. Sachin Jagdale provides more details.¹

read more | digg story


Bookmark and Share